User profiles for Kiran Pingali

Subramanya Ravi Kiran Pingali

Austin Community College
Verified email at austincc.edu
Cited by 236

Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation

SRK Pingali, MA Mathiason, SD Lovrich… - Clinical Lymphoma and …, 2009 - Elsevier
We report the emergence of chronic myelogenous leukemia (CML) in a patient with
JAK2V617F-positive polycythemia vera after 15 years of phlebotomy. The polycythemia vera clinical …

Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry

…, IW Tremont, B Teh, S Ganguly, SRK Pingali - Annals of …, 2023 - Springer
Primary central nervous system lymphoma (PCNSL) is an aggressive subtype of non-Hodgkin
lymphoma that carries a poor prognosis in the elderly. The aim of this study is to …

Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation

…, JM McCarty, S Ravi Kiran Pingali… - British journal of …, 2021 - Wiley Online Library
In young and fit patients with mantle cell lymphoma (MCL), intensive induction therapy followed
by a consolidative autologous haematopoietic cell transplant (autoHCT) is the standard …

[HTML][HTML] Opportunistic infections in patients receiving daratumumab regimens for multiple myeloma (MM)

…, SS Shah, JH Petkova, S Ganguly, L Rice, SRK Pingali - Blood, 2021 - Elsevier
Background Daratumumab-based treatment regimens for MM have improved outcomes for
both transplant-eligible and ineligible patients. As a result, patients are receiving longer …

[HTML][HTML] Comparative review of 30 day non-relapse mortality (NRM) in B-cell lymphomas associated with anti-CD19 chimeric antigen receptor T-cells (CAR-T) from …

E Burns, K Anand, JR Westin, SRK Pingali, J Ensor… - Blood, 2019 - Elsevier
Introduction CAR-T cells targeting CD19 positive B-cells have improved outcomes and
remission rates in relapsed/refractory non-Hodgkin lymphoma (NHL) and B-cell acute …

Immune Checkpoint Inhibitor-Related Cardiotoxicity.

…, R Araujo-Gutierrez, SRK Pingali - Methodist DeBakey …, 2018 - europepmc.org
DISCUSSION Apical aneurysm in hypertrophic cardiomyopathy (HCM) is a relatively under-diagnosed
finding with reported diagnosed incidences of 2% to 3% in patients with apical …

[PDF][PDF] Seeking Optimal ETF Execution in Electronic Markets

K Pingali, J Liu, S Park, M Baradas - Journal of Trading, 2014 - smallake.kr
Exchange-traded funds (ETFs) have been, since their inception, a revolutionary change for
investors and those in the investing business. There are a few key characteristics of ETFs that …

[HTML][HTML] Relationship between poverty rate and survival for diffuse large B-cell lymphoma

K Anand, SRK Pingali, J Ensor - Blood, 2020 - Elsevier
Introduction: Population based studies previously have shown that age, race and neighborhood
socioeconomic status (SES) influence survival in diffuse large B-cell lymphoma (DLBCL)…

[HTML][HTML] Primary Cutaneous Anaplastic Large-Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis from 2005-2016

…, J Ensor, A Puri, JK Randhawa, SS Shah, SRK Pingali - Blood, 2019 - Elsevier
Introduction Primary cutaneous anaplastic large-cell lymphoma (PCALCL) is a rare T-cell
lymphoma that presents as a solitary or grouped nodules. It is characterized by anaplastic-…

[PDF][PDF] Macrophage activation syndrome secondary to underlying sarcoidosis

S Kasparian, K Anand, E Burns, B Chung, SRK Pingali - Cureus, 2019 - cureus.com
Hemophagocytic lymphohistiocytosis (HLH) due to an underlying rheumatologic condition
is known as macrophage activation syndrome (MAS), a rare and serious complication that …